$0.43 Earnings Per Share Expected for Phibro Animal Health Corp (PAHC) This Quarter
Analysts expect Phibro Animal Health Corp (NASDAQ:PAHC) to post earnings of $0.43 per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Phibro Animal Health’s earnings, with the lowest EPS estimate coming in at $0.41 and the highest estimate coming in at $0.44. Phibro Animal Health reported earnings of $0.38 per share during the same quarter last year, which indicates a positive year over year growth rate of 13.2%. The firm is expected to issue its next quarterly earnings report on Monday, November 5th.
According to Zacks, analysts expect that Phibro Animal Health will report full year earnings of $1.80 per share for the current financial year, with EPS estimates ranging from $1.75 to $1.87. For the next fiscal year, analysts anticipate that the company will report earnings of $1.89 per share, with EPS estimates ranging from $1.88 to $1.90. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research analysts that cover Phibro Animal Health.
Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Monday, August 27th. The company reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.04. Phibro Animal Health had a return on equity of 39.81% and a net margin of 7.90%. The company had revenue of $211.80 million for the quarter, compared to the consensus estimate of $209.27 million. During the same quarter in the previous year, the business earned $0.39 EPS. Phibro Animal Health’s revenue was up 8.7% compared to the same quarter last year.
In other Phibro Animal Health news, major shareholder Bfi Co., Llc sold 9,470 shares of the company’s stock in a transaction that occurred on Tuesday, July 17th. The stock was sold at an average price of $48.20, for a total transaction of $456,454.00. Following the transaction, the insider now owns 47,470 shares in the company, valued at approximately $2,288,054. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jack Bendheim sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, August 6th. The stock was sold at an average price of $50.66, for a total value of $506,600.00. Following the transaction, the chief executive officer now owns 8,000 shares in the company, valued at approximately $405,280. The disclosure for this sale can be found here. Insiders have sold a total of 343,960 shares of company stock worth $16,571,627 in the last quarter. Company insiders own 51.88% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Royal Bank of Canada grew its holdings in shares of Phibro Animal Health by 2,104.6% during the 1st quarter. Royal Bank of Canada now owns 3,814 shares of the company’s stock worth $151,000 after acquiring an additional 3,641 shares during the period. Meeder Asset Management Inc. boosted its position in shares of Phibro Animal Health by 149.2% in the 2nd quarter. Meeder Asset Management Inc. now owns 4,470 shares of the company’s stock worth $206,000 after purchasing an additional 2,676 shares in the last quarter. Piedmont Investment Advisors LLC bought a new stake in shares of Phibro Animal Health in the 2nd quarter worth approximately $213,000. Janus Henderson Group PLC bought a new stake in shares of Phibro Animal Health in the 2nd quarter worth approximately $222,000. Finally, Highbridge Capital Management LLC bought a new stake in shares of Phibro Animal Health in the 1st quarter worth approximately $214,000. Hedge funds and other institutional investors own 49.20% of the company’s stock.
Shares of NASDAQ:PAHC opened at $42.30 on Thursday. Phibro Animal Health has a 1 year low of $32.05 and a 1 year high of $54.62. The stock has a market cap of $1.71 billion, a P/E ratio of 24.31, a price-to-earnings-growth ratio of 2.44 and a beta of 0.89. The company has a current ratio of 2.90, a quick ratio of 1.66 and a debt-to-equity ratio of 1.62.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 26th. Shareholders of record on Wednesday, September 5th will be issued a dividend of $0.10 per share. The ex-dividend date of this dividend is Tuesday, September 4th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.95%. Phibro Animal Health’s dividend payout ratio (DPR) is 22.99%.
About Phibro Animal Health
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.
Featured Article: Understanding Relative Strength Index
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.